MIRM FY 2024 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$337M+80.8% YoY

Gross Profit

$255M75.8% margin

Operating Income

-$88M-26.0% margin

Net Income

-$88M-26.1% margin

EPS (Diluted)

$-1.85

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$9M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$671M

Total Liabilities

$445M

Stockholders' Equity

$226M

Cash & Equivalents

$223M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$337M	$186M	+80.8%
Gross Profit	$255M	$139M	+83.2%
Operating Income	-$88M	-$109M	+19.7%
Net Income	-$88M	-$163M	+46.2%